☆ 4.8 Review

Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Dopamine, Immunity, and Disease

Breana Channer et al.

Summary: Dopamine plays a crucial role in CNS function, regulating reward, movement, and cognition. It also regulates vital functions in peripheral organs and acts as an immunoregulatory factor. Despite inconsistent and poorly understood data, targeting dopaminergic pathways could be promising for inflammation and disease treatment. This review integrates current knowledge on the role of dopamine in immune cell function and inflammatory signaling across systems and highlights its importance in various diseases. Rating: 8/10.

PHARMACOLOGICAL REVIEWS (2023)

Add to Collection

Article Pharmacology & Pharmacy

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Yang Liu et al.

Summary: The study demonstrates the involvement of ASCT2 in the progression of Parkinson's disease, with high expression correlated with dyskinesia. It further shows that genetic ablation of astrocytic ASCT2 alleviates neuroinflammation and rescues dopaminergic neuron damage. The drug talniflumate, identified through virtual molecular screening, inhibits astrocytic inflammation and prevents degeneration of dopaminergic neurons in Parkinson's disease models.

ACTA PHARMACEUTICA SINICA B (2023)

Add to Collection

Review Clinical Neurology

Impaired dopamine release in Parkinson's disease

Kaitlyn M. L. Cramb et al.

Summary: Cramb et al. provide a review of evidence suggesting dopamine release deficits occur prior to neurodegeneration in Parkinson's disease. They also highlight the need for further investigation in understanding the mechanisms behind these deficits.

BRAIN (2023)

Add to Collection

Article Clinical Neurology

Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease

Zekun Zheng et al.

Summary: This study examined the longitudinal association of frailty with the development of Parkinson's disease (PD) and found that physical prefrailty and frailty were associated with incident PD, with a higher risk observed in individuals with frailty and high genetic risk.

JAMA NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease

Thiago P. Leal et al.

Summary: This study conducted the first X-chromosome-wide association study for PD risk in a Latin American cohort, identifying eight linkage disequilibrium regions associated with PD. One of these regions (rs5525496) is associated with multiple expression quantitative trait loci in brain and non-brain tissues, but colocalization analysis suggests that it may not mediate risk through the expression of these genes. The study also replicated a previous finding from an X-chromosome-wide association study, showing an association between rs28602900 and PD in non-European populations.

MOVEMENT DISORDERS (2023)

Add to Collection

Article Neurosciences

ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage

Yuhao Yuan et al.

Summary: This study examined the effects of an astrocyte regulator (ONO-2506) on levodopa-induced dyskinesia (LID) in a rat model of Parkinson's disease. The results showed that ONO-2506 significantly delayed the development of LID in the early stage of L-DOPA treatment. However, it had no significant effect on motor function improvement. The study suggests that interventions targeting astrocytes and glutamate transporters may be potential therapeutic strategies to delay the development of LID.

NEUROSCIENCE (2023)

Add to Collection

Review Cell Biology

Urgent needs of caregiving in ageing populations with Alzheimer's disease and other chronic conditions: Support our loved ones

John W. Culberson et al.

Summary: This article discusses the origins and effects of the ageing process, emphasizing the pressure age-related diseases put on caregivers and families. It also explores innovative approaches to improve the medical system, funding for caregiving, and the skills and efficiency of caregivers. Overall, there is an urgent need for caregiving and support for the elderly population.

AGEING RESEARCH REVIEWS (2023)

Add to Collection

Article Immunology

Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia

Glauce C. Nascimento et al.

Summary: Hydrogen gas inhalation reduces L-DOPA-induced dyskinesia by reducing inflammation, which has important implications for the treatment of Parkinson's disease.

BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Role of neuroinflammation in neurodegeneration development

Weifeng Zhang et al.

Summary: Studies have shown that inflammation plays a crucial role in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis. Protein aggregates, a common pathological phenomenon, induce neuroinflammation which worsens protein aggregation and neurodegeneration. Inflammation occurs even before protein aggregation. Genetic variations in CNS cells or peripheral immune cells can induce neuroinflammation and protein deposition. Blocking or enhancing inflammatory signaling pathways are considered promising strategies for the treatment of neurodegenerative diseases, and some have shown exciting results in animal models and clinical trials, with a few already approved by FDA for clinical usage.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Add to Collection

Article Cell Biology

Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration

Jinbin Xu et al.

Summary: Zhao et al. discovered evolutionarily conserved astrocyte and microglia subpopulations shared across multiple brain regions, revealing similarities and differences in AD and PD glia and regional variance linked to AD pathology and neurodegeneration. Their analysis identified commonalities between AD and PD astrocytes and unique transcriptomic changes in microglia for each disorder. They also delineated undescribed subpopulations of medium spiny neurons (MSNs) and provided neuronal transcriptomic profiles suggesting disease-specific changes and selective vulnerability.

NATURE AGING (2023)

Add to Collection

Article Clinical Neurology

Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease

Zekun Zheng et al.

Summary: The study found a significant association between frailty and the development of PD, with a stronger impact of frailty in individuals with high genetic risk. These findings may have important implications for the assessment and management of frailty in PD prevention.

JAMA NEUROLOGY (2023)

Add to Collection

Article Neurosciences

Astrocytes Render Memory Flexible by Releasing D-Serine and Regulating NMDA Receptor Tone in the Hippocampus

Wuhyun Koh et al.

Summary: This study found that hippocampal astrocytes regulate NMDAR tone by releasing D-serine and glutamate, with the process mediated by BEST1. Decreased NMDAR tone results in impaired cognitive flexibility, and NMDAR tone during initial learning is crucial for subsequent learning.

BIOLOGICAL PSYCHIATRY (2022)

Add to Collection

Article Pharmacology & Pharmacy

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease

Yuejun Wang et al.

Summary: CD44 plays a crucial role in neuroinflammation and may be involved in the progression of Parkinson's disease. This study reveals that CD44 deficiency can inhibit the expression of proinflammatory cytokines and improve behavioral defects in PD model mice. Neutralization of CD44 with antibodies produces similar effects.

PHARMACOLOGICAL RESEARCH (2022)

Add to Collection

Article Psychiatry

N-Methyl-D-Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia

Tasnim Rahman et al.

Summary: Lower levels of N-methyl-D-aspartate receptor (NMDAR) GluN1 subunit and heightened neuroinflammation are found in the cortex in schizophrenia. Changes in NMDAR composition, specifically the ratios of GluN2A:GluN2B binding and GRIN2A:GRIN2B mRNA, are associated with inflammation in schizophrenia cases.

SCHIZOPHRENIA RESEARCH (2022)

Add to Collection

Review Neurosciences

Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration

Manish Verma et al.

Summary: Glutamate is a commonly used neurotransmitter in the central nervous system of mammals, but excessive levels can lead to excitotoxicity and neuronal cell death. Excitatory synaptic dysregulation also contributes to neurodegeneration. Optimizing mitochondrial calcium flux can prevent excitatory mitochondrial toxicity and provide neuroprotection in various diseases.

TRANSLATIONAL NEURODEGENERATION (2022)

Add to Collection

Article Neurosciences

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

Mariangela Scarduzio et al.

Summary: This review provides an overview of synaptic dysfunctions and neurochemical alterations in hyperkinetic movement disorders, including changes in synaptic plasticity and neuromodulation.

NEUROBIOLOGY OF DISEASE (2022)

Add to Collection

Article Cell Biology

NMDA receptor-dependent prostaglandin-endoperoxide synthase 2 induction in neurons promotes glial proliferation during brain development and injury

Jia Zhou et al.

Summary: The study reveals that astrocyte proliferation is regulated by neuronal activity through NMDA receptor signaling, and the expression of Ptgs(2) induced by NMDAR activation in neurons plays a crucial role in activity-dependent astrocyte proliferation.

CELL REPORTS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence

Ritam Bandopadhyay et al.

Summary: This study focuses on the recent updates in molecular mechanisms and therapeutic approaches for the effective management of levodopa-induced dyskinesia (LID) in Parkinson's disease patients.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Cerebral Glutamate Regulation and Receptor Changes in Perioperative Neuroinflammation and Cognitive Dysfunction

Yan Zhang et al.

Summary: This article reviews how glutamate handling and glutamatergic function are affected by neuroinflammation and their contribution to cognitive impairment. The authors summarize the current data regarding glutamate in neurotransmission, including its receptors and regulation. They also examine the impact of inflammation on glutamate handling and neurotransmission, focusing on changes in glial cells and the effect of cytokines. Finally, they discuss the implications of these changes for perioperative neuroinflammation and perioperative neurocognitive disorders.

BIOMOLECULES (2022)

Add to Collection

Review Oncology

Microglia and metastases to the central nervous system: victim, ravager, or something else?

Maria M. Caffarel et al.

Summary: This review summarizes the findings on microglia heterogeneity from classical studies to the new single-cell omics. It discusses the interaction between microglia and metastatic cancer cells in the unique brain tumor microenvironment, the limitations of the microglia classical M1-M2 binary concept, and the single-cell omic findings that help understand microglia heterogeneity and functions in CNS metastasis. The review also proposes ways to exploit microglia plasticity for brain metastasis treatment depending on the microenvironment profile.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Gliotransmission of D-serine promotes thirst-directed behaviors in Drosophila

Annie Park et al.

Summary: Using single-cell sequencing, molecular and cellular adaptations in the brain of water-deprived Drosophila were identified. The study revealed that water deficiency primarily affected the glial transcriptome, with astrocytes playing a key role in regulating water consumption through the synthesis and release of the gliotransmitter D-serine. This finding suggests that thirst can elevate astrocytic D-serine release to enhance water procurement.

CURRENT BIOLOGY (2022)

Add to Collection

Article Immunology

Transient neuroinflammation following surgery contributes to long-lasting cognitive decline in elderly rats via dysfunction of synaptic NMDA receptor

Bo Chen et al.

Summary: The transient neuroinflammation induced by surgery contributes to the development of PNDs in elderly rats through sustained downregulation and hypofunction of synaptic NR2A and NR2B subunits.

JOURNAL OF NEUROINFLAMMATION (2022)

Add to Collection

Article Neurosciences

Selective Ablation of Sod2 in Astrocytes Induces Sex-Specific Effects on Cognitive Function, D-Serine Availability, and Astrogliosis

Matthew P. Baier et al.

Summary: This study investigates the impact of reduced mitochondrial antioxidant response in astrocytes on cognitive function and neuronal activity. The findings suggest that decreasing antioxidant stress in astrocytes replicates age-related cognitive deficits, decreased availability of D-serine, and enhanced astrogliosis, indicating that improving astrocyte mitochondrial homeostasis may be a therapeutic target for addressing cognitive impairment in aging.

JOURNAL OF NEUROSCIENCE (2022)

Add to Collection

Article Medicine, Research & Experimental

Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats

Yasmena O. Azar et al.

LIFE SCIENCES (2022)

Add to Collection

Article Neurosciences

Microglia states and nomenclature: A field at its crossroads

Rosa C. Paolicelli et al.

NEURON (2022)

Add to Collection

Review Clinical Neurology

Microglia as Central Protagonists in the Chronic Stress Response

Eva Schramm et al.

Summary: Chronic stress is a major risk factor for psychiatric conditions, and it activates the immune system, alters the phenotype of microglia, and affects the CNS environment.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Add to Collection

Review Pharmacology & Pharmacy

Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing

Valentina Cesaroni et al.

Summary: LIDs are supported by complex molecular and neurobiological mechanisms that are still being studied today. This complexity suggests the need of developing personalized pharmacological approach to obtain an effective amelioration of LID condition and improve the quality of life of PD patients.

EXPERT OPINION ON THERAPEUTIC TARGETS (2022)

Add to Collection

Article Neurosciences

α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss

Dorit Trudler et al.

Summary: In Parkinson's disease, synaptic and neuronal loss are prominent features. The study reveals that alpha Syn oligomers induce excessive glutamate release from astrocytes, activating NMDARs on neurons and leading to synaptic damage. However, the drug NitroSynapsin shows promise in protecting synapses from alpha Syn-induced damage.

JOURNAL OF NEUROSCIENCE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease

Mauricio dos Santos Pereira et al.

Summary: The study aimed to characterize mechanisms regulating neuroinflammation in L-DOPA-induced dyskinesia in mice, finding that astrocytic and microglial responses, as well as increased pro-inflammatory cytokine levels, were associated with LID development. Treatment with cannabidiol and capsazepine reduced LID severity and TNF-alpha levels, suggesting a potential therapeutic approach. Glutamate-induced TNF-alpha release from astrocytes may contribute to LID by modulating corticostriatal glutamatergic inputs, with cannabidiol + capsazepine attenuating this effect.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Neurosciences

Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment

Ayumi E. Pottenger et al.

Summary: The study demonstrated that sub-anesthetic ketamine can alleviate motor dysfunction in Parkinson's disease patients caused by prolonged use of L-DOPA. The mechanism of ketamine's therapeutic effects may involve inflammation and microglia phagocytic functions.

NEUROSCIENCE LETTERS (2021)

Add to Collection

Article Pharmacology & Pharmacy

The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-D-Aspartate Receptors

Riley E. Perszyk et al.

Summary: NMDA receptors play a crucial role in brain functions and are implicated in various neurological conditions. The negative allosteric modulator EU1794-4 reduces overall current flow after receptor activation and Ca2+ flux through the receptors, showing therapeutic potential for neurodegenerative diseases and acute injuries.

MOLECULAR PHARMACOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases

Juan Jose Trivino et al.

Summary: Microglia play crucial roles in the CNS by regulating synapses and the neuronal network, responding to signals to protect the CNS, and influencing neuroinflammation and oxidative stress associated with aging and neurodegenerative diseases. Dysregulation of microglia function in aging may lead to cognitive dysfunction and increase susceptibility to neurodegeneration.

NEUROCHEMISTRY INTERNATIONAL (2021)

Add to Collection

Article Clinical Neurology

Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease

Seok Jong Chung et al.

Summary: Enlarged perivascular spaces (PVS) in the basal ganglia are associated with the progression of motor disability in Parkinson's disease (PD). Patients with a higher number of enlarged PVS require higher doses of dopaminergic medications for symptom control, and they are at higher risk for freezing of gait.

NEUROLOGY (2021)

Add to Collection

Article Neurosciences

Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson's Disease and L-DOPA-Induced Dyskinesia

D. P. Ferrari et al.

Summary: The absence of IFN-gamma intensifies the inflammatory reaction during L-DOPA treatment, but does not affect the degeneration of dopaminergic neurons or LID development.

NEUROTOXICITY RESEARCH (2021)

Add to Collection

Article Geriatrics & Gerontology

Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway

Aijuan Yan et al.

Summary: Systemic inflammation exacerbates levodopa-induced dyskinesia (LID) by increasing neuroinflammation and NR2B subunit activity. The use of clodronate-encapsulated liposomes can suppress the inflammatory response and improve behavioral dysfunction, reducing susceptibility to LID.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Icariin ameliorates partial sciatic nerve ligation induced neuropathic pain in rats: an evidence of in silico and in vivo studies

Swapna Pokkula et al.

Summary: Icariin (ICA) shows promise in alleviating neuropathic pain by inhibiting NR2B, TRPV1 receptors, and Cav2.2 channels, reducing inflammation and apoptosis in the bodies of patients with neuropathic pain.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)

Add to Collection

Article Cell Biology

TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration

Kaspar Russ et al.

Summary: TNF-alpha and alpha-synuclein fibrils induce distinct immune reactive responses in astrocytes, accompanied by impaired mitochondrial respiration, with competition between the two stimuli. This study provides evidence for astrocytic involvement in Parkinson's disease pathology and highlights the complex immune reactive responses of astrocytes to exogenous stressors.

CELL REPORTS (2021)

Add to Collection

Article Neurosciences

Astrocyte-selective STAT3 knockdown rescues methamphetamine withdrawal-disrupted spatial memory in mice via restoring the astrocytic capacity of glutamate clearance in dCA1

Pengbo Shi et al.

Summary: The study revealed that METH withdrawal disrupted spatial memory in mice, associated with increased Glu levels and postsynaptic neuronal activities at dCA1 synapses. METH withdrawal weakened the capacity of Glu clearance in astrocytes, while it did not affect the presynaptic Glu release from dCA3 within dCA1.

GLIA (2021)

Add to Collection

Article Multidisciplinary Sciences

A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis

Martina Absinta et al.

Summary: Through MRI-guided single-nucleus RNA sequencing, a diversity of glial and immune cells at the edge of demyelinated white matter lesions in multiple sclerosis (MS) have been identified, along with the definition of inflamed glial cell phenotypes in MS. The overlap of the transcriptional profile of microglia inflamed in MS with that in other neurodegenerative diseases suggests common mechanisms between primary and secondary neurodegeneration that could benefit from similar therapeutic approaches. The critical role of complement component 1q (C1q) in the activation of microglia inflamed in MS has been identified and potential therapeutic avenues, such as C1q inhibition, have been suggested for addressing chronic white matter inflammation.

NATURE (2021)

Add to Collection

Review Neurosciences

Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease

Kendra L. Hanslik et al.

Summary: Glial cells in the CNS play important roles in support and immune response, and their function can be affected by aging and neurodegenerative diseases. Glia may contribute to the pathogenesis of various neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Add to Collection

Review Immunology

Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?

Yan-mei Qiu et al.

Summary: Blood-Brain Barrier (BBB) disruption is a crucial pathophysiological process in acute ischemic stroke, where the rapid activation of immune cells plays a critical role. Infiltrating immune cells increase BBB permeability, causing microvascular disorder, but also promote BBB repair and angiogenesis. Understanding the inflammatory mechanisms behind BBB disruption can lead to the development of more effective therapeutics for acute ischemic stroke.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats

Chang-Qing Zheng et al.

Summary: Resveratrol (RES) has shown potential in alleviating dyskinesia associated with Parkinson's disease treatment, reducing the abnormal movements induced by L-DOPA while protecting DA neurons from long-term damage, and inhibiting neuroinflammatory reactions mediated by glial cells.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Neurosciences

Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?

Efthalia Angelopoulou et al.

Summary: The exact etiology of Parkinson's disease (PD) is still unknown, and there is no cure for PD. Fyn, a tyrosine phospho-transferase, may play a crucial role in the pathogenesis of PD and levodopa-induced dyskinesia (LID) by regulating key signaling pathways. Therapeutic targeting of Fyn or Fyn-related pathways could represent a novel approach in PD treatment.

MOLECULAR NEUROBIOLOGY (2021)

Add to Collection

Article Neurosciences

Targeting the cannabinoid receptor CB2 in a mouse model of 1-dopa induced dyskinesia

Peggy Rentsch et al.

NEUROBIOLOGY OF DISEASE (2020)

Add to Collection

Article Critical Care Medicine

Agmatine Protects Against the Progression of Sepsis Through the Imidazoline I2 Receptor-Ribosomal S6 Kinase 2-Nuclear Factor-κB Signaling Pathway

Xuanfei Li et al.

CRITICAL CARE MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Pharmacology & Pharmacy

Subunit-specific effects of poricoic acid A on NMDA receptors

Jaeeun Lee et al.

PHARMACOLOGICAL REPORTS (2020)

Add to Collection

Article Medicine, Research & Experimental

Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine

Weixing Shen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Immunology

Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson's disease

Cynthia Lecours et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Add to Collection

Article Neurosciences

ATP Signaling Controlling Dyskinesia Through P2X7 Receptors

Analu A. Fonteles et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Add to Collection

Article Neurosciences

D-Serine Signaling and NMDAR-Mediated Synaptic Plasticity Are Regulated by System A-Type of Glutamine/D-Serine Dual Transporters

Oded Bodner et al.

JOURNAL OF NEUROSCIENCE (2020)

Add to Collection

Article Geriatrics & Gerontology

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

Valeria Calabrese et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Add to Collection

Review Neurosciences

Neuromodulation of Glial Function During Neurodegeneration

Rebecca Stevenson et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Add to Collection

Review Neurosciences

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Hyuk Sung Kwon et al.

TRANSLATIONAL NEURODEGENERATION (2020)

Add to Collection

Article Neurosciences

Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia

Mitchell J. Bartlett et al.

EXPERIMENTAL NEUROLOGY (2020)

Add to Collection

Letter Clinical Neurology

The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study

James A. Varley et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Article Neurosciences

NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology

Manuela Mellone et al.

NEUROBIOLOGY OF DISEASE (2019)

Add to Collection

Review Chemistry, Medicinal

Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention

Yujeong Lee et al.

ARCHIVES OF PHARMACAL RESEARCH (2019)

Add to Collection

Article Neurosciences

Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease

James Keaney et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)

Add to Collection

Article Clinical Neurology

Loss of STEP61 couples disinhibition to N-methyl-D-aspartate receptor potentiation in rodent and human spinal pain processing

Annemarie Dedek et al.

BRAIN (2019)

Add to Collection

Article Clinical Neurology

Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease

Anna Delamarre et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Add to Collection

Article Endocrinology & Metabolism

Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder

Stuart Innes et al.

PSYCHONEUROENDOCRINOLOGY (2019)

Add to Collection

Article Neurosciences

Endogenous Glutamate Excites Myenteric Calbindin Neurons by Activating Group I Metabotropic Glutamate Receptors in the Mouse Colon

Mathusi Swaminathan et al.

FRONTIERS IN NEUROSCIENCE (2019)

Add to Collection

Review Immunology

An update on reactive astrocytes in chronic pain

Ting Li et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Add to Collection

Article Clinical Neurology

Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Laura Boi et al.

MOVEMENT DISORDERS (2019)

Add to Collection

Article Neurosciences

Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors

Ankur Jindal et al.

NEUROBIOLOGY OF DISEASE (2019)

Add to Collection

Article Geriatrics & Gerontology

Late aging-associated increases in L-DOPA-induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat

Kathryn Lanza et al.

NEUROBIOLOGY OF AGING (2019)

Add to Collection

Article Medicine, General & Internal

Parkinson's Disease

Stephen G. Reich et al.

MEDICAL CLINICS OF NORTH AMERICA (2019)

Add to Collection

Article Psychology, Biological

NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease

Mohammad Amani et al.

PHYSIOLOGY & BEHAVIOR (2019)

Add to Collection

Editorial Material Clinical Neurology

Neuroinflammation: Fanning the Fire of L-Dopa-Induced Dyskinesia

Christopher Bishop

MOVEMENT DISORDERS (2019)

Add to Collection

Article Neurosciences

Synaptic plasticity may underlie L-DOPA induced dyskinesia

Anders Borgkvist et al.

CURRENT OPINION IN NEUROBIOLOGY (2018)

Add to Collection

Review Clinical Neurology

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors

Tai N. Tran et al.

JOURNAL OF NEURAL TRANSMISSION (2018)

Add to Collection

Article Neurosciences

Inhibition of striatal cholinergic interneuron activity by the Kv7 opener retigabine and the nonsteroidal anti-inflammatory drug diclofenac

Rodrigo Manuel Paz et al.

NEUROPHARMACOLOGY (2018)

Add to Collection

Article Neurosciences

Ketamine-induced neurotoxicity blocked by N-Methyl-D-aspartate is mediated through activation of PKC/ERK pathway in developing hippocampal neurons

Sufang Jiang et al.

NEUROSCIENCE LETTERS (2018)

Add to Collection

Article Neurosciences

Diversity of Astroglial Effects on Aging- and Experience-Related Cortical Metaplasticity

Ulyana Lalo et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Add to Collection

Article Clinical Neurology

Neuromodulatory Effect of Thymoquinone in Attenuating Glutamate-Mediated Neurotoxicity Targeting the Amyloidogenic and Apoptotic Pathway

Ibram Amin Fouad et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

Modulation of CaMKIIa-GluN2B interaction in levodopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's rats

Xin-Shi Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Article Neurosciences

The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia

Andrew J. Flores et al.

NEUROPHARMACOLOGY (2018)

Add to Collection

Article Psychiatry

Low plasma concentrations of N-methyl-D-aspartate receptor subunits as a possible biomarker for psychosis

C. M. Loureiro et al.

SCHIZOPHRENIA RESEARCH (2018)

Add to Collection

Article Neurosciences

l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?

Anna R. Carta et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2017)

Add to Collection

Article Neurosciences

Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses

Rosa Calvello et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons

Jeremie Lavaur et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Add to Collection

Article Multidisciplinary Sciences

Longistyline C acts antidepressant in vivo and neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in PC12 cells

Yamin Liu et al.

PLOS ONE (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Current disease modifying approaches to treat Parkinson's disease

Dan Lindholm et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Add to Collection

Article Neurosciences

mGlu5, Dopamine D-2 and Adenosine A(2A) Receptors in L-DOPA-induced Dyskinesias

Nicolas Morin et al.

CURRENT NEUROPHARMACOLOGY (2016)

Add to Collection

Correction Neurosciences

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia (vol 88, pg 762, 2015)

Weixing Shen et al.

NEURON (2016)

Add to Collection

Review Neurosciences

Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia

Qiang Wang et al.

FRONTIERS IN NEURAL CIRCUITS (2016)

Add to Collection

Article Clinical Neurology

Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias

Scott J. Sherman et al.

CASE REPORTS IN NEUROLOGY (2016)

Add to Collection

Article Neurosciences

Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia

Milica Cerovic et al.

BIOLOGICAL PSYCHIATRY (2015)

Add to Collection

Review Medicine, Research & Experimental

Regulating G protein activity by lipase-independent functions of phospholipase C

Irene Litosch

LIFE SCIENCES (2015)

Add to Collection

Article Neurosciences

Glial activation is associated with L-DOPA induced dysldnesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease

Mariza Bortolanza et al.

NEUROBIOLOGY OF DISEASE (2015)

Add to Collection

Article Neurosciences

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Weixing Shen et al.

NEURON (2015)

Add to Collection

Article Multidisciplinary Sciences

Phosphorylation of NR2B NMDA subunits by protein kinase C in arcuate nucleus contributes to inflammatory pain in rats

Fan Bu et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Clinical Neurology

Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats

Hongjuan Shi et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)

Add to Collection

Review Clinical Neurology

Therapeutic potential of targeting glutamate receptors in Parkinson's disease

Clare Finlay et al.

JOURNAL OF NEURAL TRANSMISSION (2014)

Add to Collection

Article Neurosciences

Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and L-DOPA induced dyskinesia in mouse models

Sherri L. Thiele et al.

NEUROBIOLOGY OF DISEASE (2014)

Add to Collection

Review Clinical Neurology

Pharmacological treatments inhibiting levodopa-induced dyskinesias in MPTP-lesioned monkeys: brain glutamate biochemical correlates

Nicolas Morin et al.

FRONTIERS IN NEUROLOGY (2014)

Add to Collection

Article Neurosciences

Expression, subunit composition, and function of AMPA-type glutamate receptors are changed in activated microglia; possible contribution of GluA2 (GluR-B)-deficiency under pathological conditions

Kaoru Beppu et al.

GLIA (2013)

Add to Collection

Article Neurosciences

Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity

Ingrid Morales et al.

GLIA (2012)

Add to Collection

Article Medicine, Research & Experimental

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

Gregory Porras et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Add to Collection

Article Immunology

L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation

Junpei Takaki et al.

JOURNAL OF NEUROINFLAMMATION (2012)

Add to Collection

Article Neurosciences

Effects of L-DOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson's disease

Adrien Quintana et al.

NEUROBIOLOGY OF DISEASE (2012)

Add to Collection

Article Chemistry, Multidisciplinary

Enhanced NMDA receptor NR1 phosphorylation and neuronal activity in the arcuate nucleus of hypothalamus following peripheral inflammation

Jian-ming Peng et al.

ACTA PHARMACOLOGICA SINICA (2011)

Add to Collection

Article Clinical Neurology

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

K. Elisabet Ohlin et al.

BRAIN (2011)

Add to Collection

Review Geriatrics & Gerontology

Factors related to functional independence in females with Parkinson's disease: A systematic review

Kaitlyn P. Roland et al.

MATURITAS (2011)

Add to Collection

Article Multidisciplinary Sciences

Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses

Junqiang Yan et al.

PLOS ONE (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Synaptic dysfunction in Parkinson's disease

Vincenza Bagetta et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2010)

Add to Collection

Article Neurosciences

Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-d-aspartate receptors

Adrien Quintana et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2010)

Add to Collection

Article Biochemistry & Molecular Biology

NMDA receptor, PKC and ERK prevent fos expression induced by the activation of group I metabotropic glutamate receptors in the spinal trigeminal subnucleus oralis

Eun-sung Park et al.

MOLECULES AND CELLS (2010)

Add to Collection

Article Clinical Neurology

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

I. A. Prescott et al.

BRAIN (2009)

Add to Collection

Article Biochemistry & Molecular Biology

A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death

Kaoru Saijo et al.

CELL (2009)

Add to Collection

Article Neurosciences

Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra

Vikas Kaushal et al.

JOURNAL OF NEUROSCIENCE (2008)

Add to Collection

Article Neurosciences

Switch to Ca2+-permeable AMPA and reduced NR2B NMDA receptor-mediated neurotransmission at dorsal horn nociceptive synapses during inflammatory pain in the rat

Kristina S. Vikman et al.

JOURNAL OF PHYSIOLOGY-LONDON (2008)

Add to Collection

Article Neurosciences

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease

E. L. Lane et al.

NEUROBIOLOGY OF DISEASE (2008)

Add to Collection

Article Neurosciences

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat

Kristin B. Dupre et al.

PSYCHOPHARMACOLOGY (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Changes in suhcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and L-dopa-treated rats

Maowen Ba et al.

NEUROCHEMICAL RESEARCH (2006)

Add to Collection

Review Biochemistry & Molecular Biology

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

Yoon Seong Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2006)

Add to Collection

Article Biochemistry & Molecular Biology

Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner

Hideyuki Takeuchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Add to Collection

Article Biochemistry & Molecular Biology

Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport

H Takeuchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Review Clinical Neurology

Natural history and syndromic associations of orthostatic tremor:: A review of 41 patients

W Gerschlager et al.

MOVEMENT DISORDERS (2004)

Add to Collection

Article Neurosciences

Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia

W Guo et al.

JOURNAL OF NEUROSCIENCE (2004)

Add to Collection

Article Neurosciences

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

F Calon et al.

NEUROBIOLOGY OF DISEASE (2003)

Add to Collection

Article Neurosciences

The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1

G Krapivinsky et al.

NEURON (2003)

Add to Collection

Article Neurosciences

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

B Picconi et al.

NATURE NEUROSCIENCE (2003)

Add to Collection

Article Biochemistry & Molecular Biology

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

K Sriram et al.

FASEB JOURNAL (2002)

Add to Collection

Article Multidisciplinary Sciences

Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity

HK Lee et al.

NATURE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.